Comparison of the Effects of Interscalene Block and Superior Trunk Block on Pulmonary Functions

December 15, 2025 updated by: Beyza Büyükgebiz Yeşil, Gazi University

Comparison of the Effects of Interscalene Block and Superior Trunk Block on Pulmonary Functions for Shoulder Arthroscopic Surgery Patients

The interscalene block (ISB) is one of the peripheral nerve blocks providing surgical anesthesia and postoperative analgesia in shoulder arthroscopy, eliminating the need for general anesthesia. It is performed by administering local anesthetics (LA) to the C5-C6 roots between the scalene muscles at the level of the cricoid cartilage. ISB-related side effects, such as diaphragmatic paralysis, can occur with the spread of LA to the phrenic nerve over the anterior scalene muscle. To prevent this, a superior trunk block (STB) can be performed by administering LA close to the supraclavicular region where the C5-C6 roots merge into the superior trunk (further away from the phrenic nerve). Although there are studies in the literature demonstrating diaphragmatic paralysis using ultrasound and/or spirometry, no study evaluating diaphragmatic paralysis simultaneously with both ultrasound and spirometry under regional anesthesia alone has been found. Therefore, in this study, the investigators aim to assess the effects of this side effect on diaphragmatic excursion using ultrasound simultaneously and on respiratory functions using spirometry.

Study Overview

Detailed Description

Due to diaphragmatic paralysis, interscalene block (ISB) application is contraindicated in patients with pulmonary issues, leaving general anesthesia as the only option. However, the use of opioids for postoperative analgesia in such patients brings unwanted opioid side effects. Consequently, new approaches have emerged to prevent diaphragmatic paralysis, making peripheral blocks feasible for shoulder arthroscopies in patients with pulmonary problems. This study aims to reassess the hypothesis regarding ISB and superior trunk block (STB), routinely used for shoulder arthroscopy surgery, in patients without pulmonary issues, supported by simultaneous ultrasound measurements of diaphragmatic excursion and spirometry measurements of respiratory function. Additionally, the demographic characteristics of patients, onset time of block effects, postoperative additional analgesic requirements, durations of block effects, and times of initial analgesic needs will be observed and compared.

Research Type Description: The study is prospective randomized research. Respiratory function measurements will be taken from patients undergoing ISB and STB, which are routinely performed in brachial plexus blocks in our clinic. These measurements do not involve any invasive procedures and will be solely quantitatively assessed using ultrasound and respiratory function tests.

Case Report Form: The form that will be used is a case report form. Each participant will be assigned a unique number, and all sections related to the study will be completed for each participant.

Data Collection:

After obtaining consent from patients agreeing to participate in the study, patients will be monitored (blood pressure, heart rate, oxygen saturation), and intravenous access will be established.

Dr. Beyza Mehri Büyükgebiz Yeşil will measure diaphragmatic excursion under ultrasound guidance during deep and normal respiration on the side where the block will be performed and record the values in the case report form.

Dr. Beyza Mehri Büyükgebiz Yeşil will perform respiratory function testing with a spirometer and record the values in the case report form.

The blocks will be administered by Assoc Prof Dr. Gökçen Emmez and Prof Dr. İrfan Güngör.

Thirty minutes after the end of the block application, Dr. Beyza Mehri Büyükgebiz Yeşil will measure diaphragmatic excursion under ultrasound guidance during deep and normal respiration on the side where the block was performed and perform respiratory function testing with a spirometer and record the values in the case report form.

Blinding of the study will be ensured by having different researchers perform the block and measurements.

Prof Ulunay Kanatlı will perform the surgical procedure. Patients will be prescribed 3X1 grams of Paracetamol for routine postoperative analgesia.

The onset time of the block effect, postoperative additional analgesic requirements, duration of block effects, and time of initial analgesic needs will be observed and recorded in the case report form.

Both surgeon and patient satisfaction will be recorded in the case report form at the end of surgery. Patients will be contacted by phone one week after discharge to inquire about their current condition.

Data Analysis:

At the end of the study, data will be evaluated via case report forms and interpreted using appropriate statistical methods.

Diaphragmatic excursion change rates will be interpreted and analyzed by Prof. Dr. İrfan Güngör and Prof. Dr. Berrin Günaydın, and respiratory function values from the spirometer will be interpreted and analyzed by Prof. Dr. İpek Kıvılcım Oğuzülgen.

If continuous variables follow a normal distribution, the Student's T-test will be applied; if they do not follow a normal distribution, the Mann-Whitney U test will be applied. The Chi-square test will be applied to compare ratios. Depending on whether the data follows a normal distribution or not, Spearman or Pearson correlation tests will be applied for correlation evaluation. A p value of less than 0.05 will be considered statistically significant. Data will be presented as mean ± standard deviation, median, and n.

Study Type

Interventional

Enrollment (Actual)

123

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Ankara, Turkey (Türkiye), 06560
        • Gazi University School of Medicine

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Study Population

The study population consists of patients undergoing elective shoulder arthroplasty surgery at Gazi University Medical Faculty Hospital, Anesthesiology and Reanimation Department. Participants are selected based on their scheduled surgeries and their suitability for peripheral nerve block techniques, determined by clinical evaluation. This population includes adult patients with varying health statuses classified as ASA I-III, representing a clinical sample of individuals undergoing upper extremity orthopedic procedures.

Description

Inclusion Criteria:

  • Patients scheduled for elective shoulder arthroscopic surgery.
  • Age between 18 and 80 years.
  • American Society of Anesthesiologists (ASA) physical status I-III.
  • Written informed consent obtained.

Exclusion Criteria:

  • Refusal to undergo peripheral nerve block.
  • Pre-existing peripheral nerve disorders.
  • Known respiratory, hepatic, renal, or cardiovascular diseases.
  • Allergy to local anesthetics.
  • Active infection at the block site.
  • Body mass index (BMI) > 40 kg/m².
  • Coagulopathy or current anticoagulant therapy.
  • Sepsis or systemic infection.
  • History of prior surgery at the intended block site.
  • Neurological deficits or psychiatric disorders affecting cooperation.
  • Inability to perform spirometry or comply with study procedures.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Interscalene brachial plexus block
Patients who underwent shoulder arthroscopic surgery and recieved interscalene brachial plexus block for anesthesia before surgery
Patients assigned to the Interscalene Nerve Block would have spirometry and ultrasound-guided diaphragm excursion measurements both pre and post-blok 30 minutes.
Other Names:
  • Ultrasound
  • Spirometry
Experimental: Superior trunk brachial plexus block
Patients who underwent shoulder arthroscopic surgery and recieved superior trunk brachial plexus block for anesthesia before surgery
Patients assigned to the Superior Trunk Nerve Block would have spirometry and ultrasound-guided diaphragm excursion measurements both pre and post-blok 30 minutes.
Other Names:
  • spirometry
  • ultrasound

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Rate of Hemidiaphragmatic Paralysis
Time Frame: Baseline (pre-block) and 30 minutes post-block.

Measurement of diaphragmatic excursion (DE) in centimeters using ultrasound during normal and deep breathing. The primary aim is to compare the percentage change in DE between interscalene block (ISB) and superior trunk block (STB) groups. Diagnosis of hemidiaphragmatic paralysis based on diaphragmatic excursion reduction:

≥75% reduction classified as complete paralysis, 25-74% reduction as partial paralysis, and

≤25% reduction as no paralysis.

Baseline (pre-block) and 30 minutes post-block.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Percentage Change in Forced Expiratory Volume in 1 Second (FEV1) and Forced Vital Capacity (FVC)
Time Frame: Baseline (pre-block) and 30 minutes post-block.
Evaluation of the percentage change in FEV1 and FVC measured with spirometry between ISB and STB groups.
Baseline (pre-block) and 30 minutes post-block.
Number of Participants Requiring Additional Analgesics
Time Frame: Intraoperative period and within 24 hours postoperatively.
Comparison of additional analgesic requirements (e.g., opioids or local anesthetics) between the ISB and STB groups.
Intraoperative period and within 24 hours postoperatively.
Percentage Change in FEV1/FVC Ratio
Time Frame: Baseline (pre-block) and 30 minutes post-block.
Evaluation of the percentage change in FEV1/FVC ratio measured with spirometry between ISB and STB groups.
Baseline (pre-block) and 30 minutes post-block.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 1, 2024

Primary Completion (Actual)

January 11, 2025

Study Completion (Actual)

January 31, 2025

Study Registration Dates

First Submitted

November 21, 2024

First Submitted That Met QC Criteria

November 21, 2024

First Posted (Actual)

November 25, 2024

Study Record Updates

Last Update Posted (Actual)

December 19, 2025

Last Update Submitted That Met QC Criteria

December 15, 2025

Last Verified

December 1, 2025

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Regional Anesthesia Morbidity

Clinical Trials on Interscalene Nerve Block

Subscribe